Advertisement

Topics

Companies Related to "Evaluation of Target Organs Damage in Hypertensive Patients" [Most Relevant Company Matches] [Advanced Search Results] RSS

22:42 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Evaluation of Target Organs Damage in Hypertensive Patients" found in our extensive corporate database of over 50,000 company records.

Showing "Evaluation Target Organs Damage Hypertensive Patients" Companies 1–25 of 4,800+

Relevant

InVasc Therapeutics, Inc.

InVasc Therapeutics, Inc., headquartered in Tucker, Georgia, is a biopharmaceutical company developing drugs to mitigate risks associated with cardiometabolic diseases. Cardiovascular and metabolic diseases such as diabetes, hypertension, stroke and dyslipidemia are the leading causes of morbidity and mortality worldwide. The Company plans to file an IND l...


Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, E...

Target ALS Foundation

Target ALS is an independent, non-profit, and privately funded consortium of researchers from academic and biotech/pharma laboratories entirely focused on finding a treatment for patients living with ALS. The organization funds 19 preformed research consortia involving investigators across 30 academic institutions. Target ALS also funds Springboard Fellows...


Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

SENS Foundation

SENS Foundation is a non-profit organization founded in 2009 to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease. Our focus is SENS, a framework for repairing the damage which builds up in the body as a result of normal metabolism, before that damage leads to the development of deadly pathologies.

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2013. In addition, the company operates a credit card segment that offers branded proprietary credit card products. Since 1946, Target has given 5 percent of its income through com...

Repare Therapeutics, Inc.

Repare Therapeutics is pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in clearly defined patient populations. The company’s initial focus is on novel targeted therapies in cancer types harboring defective DNA-damage response (DDR)- or genome instability-related functions. Repare’s SNIPR...

CALIFORNIA CLINICAL THROMBOSIS CENTER

The CALIFORNIA CLINICAL THROMBOSIS CENTER is dedicated to the evaluation and management of patients with disorders of Thrombosis, Hemostasis and Vascular Medicine:AtherosclerosisHeart AttackStrokePulmonary EmbolismDeep Vein ThrombosisRecurrent MiscarriageRetinal Vascular ThrombosisUnexplained BleedingFamily History of Thrombosis or BleedingThe mission of the CALIFORNIA CLINICAL THROMBOSIS CENTER i...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target.com. Target is committed to providing a fun and convenient shopping experience with access to unique and highly differentiated products at affordable prices. Since 1946, the corporation has given 5 percent of its income through community grants and programs like Take Charge of Educa...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founded by Dr. Meinrad Good in 1993 as the pharmaceutical and biotech consulting company "BPB". In 2000, the company was re-established as "Target BioScience AG" in response to growth in international opera...

Synedgen Inc.

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree and to reduce damage and inflammation due to chemical, radiological or physical damage using the science of glycomics - the study of complex sugar structure and function. Synedgen ...

Bio-Scriptives

Bio-Scriptives was formed by BioChemics to develop the first biophysically modulated technology for skincare. Bio-Scriptives products use a technology called Derma-Release® to target specific intra-dermal skin layers, ushering in a new era in skincare treatment. The products work by manipulating blood flow, utilizing unique therapeutic and essential ext...

Cartiva, Inc.

Based in Alpharetta, Ga. and spun off from Carticept Medical, Inc. in December 2011, Cartiva, Inc. develops and markets innovative solutions for patients with osteoarthritis or cartilage damage. Major investors include Domain Associates, New Enterprise Associates and SonoSite, Inc. Additional information is available on the company’s website at http://www.ca...

BioTechPlex

BioTechPlex provides enabling products and services for the discovery and development of respiratory and cardiac drugs as well as the evaluation of respiratory, cardiac and autonomic function. BioTechPlex's technologies address unmet needs for cell-based and small animal-based assays for target screening, validation and safety pharmacology and patient monitoring and respiratory aerosol drug delive...

Pronutria Biosciences

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and are fundamental regulators of health. The entire body, ranging from microscopic cells to organs, is dependent on tightly controlled AA homeostasis. More than 2000 disorders are linked ...

Learning and Development Associates

Learning and Development Associates (LADA) is a group of professionals from medicine, psychology, education, social work and speech-language pathology concerned about development and learning patterns across the lifespan. The Adult LD-ADD Program at LADA focuses on the achievement of skills necessary to become a productive adult. We offer evaluation and treatment services to meet the needs of thos...

BurnsolutionFast, Effective Relief

The key to minimizing the damage caused by a burn is to rapidly cool the burn. The sooner the burn can be cooled, the less damage is caused to surrounding tissue.Burnaid® is a range of burn gels, gel dressings and burn kits. which offer rapid cooling to the burn, and fast ongoing pain relief.Burnaid is water soluble and non-pigmented – allowing easy assessment of the burn and can be readily rin...

Trevigen, Inc.

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. The company is located in the I-270 "High technology Corridor" in Gaithersburg, Maryland. Trevigen-brand research products are marketed via the Internet, catalog, journal advertising...

Myeloma Canada

Multiple myeloma, a cancer of the bone marrow, is an incurable but treatable disease. The cancer starts in plasma cells, which are produced in the bone marrow. In myeloma, abnormal plasma cells, called myeloma cells, grow uncontrollably, crowding out the normal blood cells in the bone. This can bring on symptoms such as fatigue, recurrent infections and se...

NeuroDigm

NeuroDigm Co. is helping companies solve the puzzle of chronic pain with the Hot Spot ModelTM of Neuropathic Pain. This is THE Alternative, Nonsurgical Model to create neuropathic pain as found in humans. The Hot Spot Model uses a gentle percutaneous procedure with a biocompatible gel to gradually over time create chronic neuropathic pain. Known pain behaviors are created without the use of o...

Theracrine, Inc.

Theracrine is a private biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer spread. To drive these efforts, Theracrine has built a robust target and drug discovery platform integrating novel molecular target identification and validation, rapid generation of lead agents, and the evaluat...

Advance Consulting & Evaluation Pty Ltd

Advance® Consulting & Evaluation Pty Ltd has merged its operations with Aoris Nova Pty Ltd and now runs under the name of Innovation Dynamics Pty Ltd. Please review the Innovation Dynamics website for current services

Carticept Medical, Inc.

Based in Alpharetta, Ga., Carticept Medical, Inc. is a privately held medical device company established in 2005 to develop innovative solutions for patients with osteoarthritis or cartilage damage. Major investors include Domain Associates and New Enterprise Associates. Additional information is available on the Company's web site at www.carticept.com.

D-TARGET SA

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent. Medical device manufacturers worldwide rely upon D-TARGET's highly trained, multi-lingual professionals for result-oriented solutions in bringing their products to life in more than 25 European count...

National Scoliosis Center

The National Scoliosis Center is committed to pursuing the non-operative treatment of scoliosis using the best available proven practices regarding diagnostics, calibration evaluation, fabrication, manufacturing, technology, and treatment. In addition to serving the needs of local patients throughout Northern Virginia; Maryland; and Washington, DC, the Cen...


More From BioPortfolio on "Evaluation of Target Organs Damage in Hypertensive Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks